Notes from UCLA David Geffen School of Medicine
Notes from UCLA David Geffen School of Medicine roundtable
Otto Yang - cell immunology and HIV talk about clinical trials regarding CV.
Views CV as three stages.
1. Infection (antiviral prevention)>
2. early phase virus induced (remdesivir) >
3. later phase hyperinflammatory (IL-6R blockers and Leronlimab)
interruptors are in parenthesis.
Huge team effort never run a clinical trial - Active clinical trials
summary of three Trials
Remdesivir. failed in ebola trial administered via IV. perhaps effective in earlier disease or as prophylaxis. Trial will continue. with remdesivir + baricitinib.
selinexor FDA approved.
exportin-1 inihibitor orally delivered Side Effects nausea & cytopenias - 1/5th of FDA dose . could reduce both viral replication and immune activation. theoritically could have viral and immunological effects. very promising, and very early
LeronLimab Trial CU - exciting used as compassionate. blocks ccr5. reduce inflammatory cell trafficking to lungs /end organs. Early anecdotal evidence for COVID 19 800 patients in HIV. extremely safe.
Leron first 5 patients UCLA. mild to moderate.
1. C-reactive proteins drop signifcantly by day 4.
2. total lymphocyte counts are down and after Lero was injected the Blood Lymphocytes rose (Good)
mentioned Pre-print RANTES disruption as well.
CYDY continuing to provide cell samples to UCLA. was mentioned
Still on the call its in Q&A right now.
11
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
When Dodge decides to hit the track running, they mean it. They're cranking the engines and returning to the NASCAR Cup Series after years in the shadows. This isn't just about going fast; it's about redefining speed on the stock car circuit and maybe even the market tickers. Revving an Old Engine for a New Race Let's get this out there: Dodge pulling a U-turn back into...
Continue Reading
A Major Milestone for Precision Medicine Ultima Genomics just nabbed a big one, folks. They're going front and center with Singapore's National Precision Medicine (NPM) Program for Phase III, marking no small feat in the ambitious world of genomics. This is more than just another feather in their cap—it's a power move in the cutthroat race for sequencing supremacy. And...
Continue Reading
Hainan Hosts a Health Heavyweight Meet Boao, Hainan, not typically on the financial radar, just played host to a global heavyweight—the 2026 International Exchange on Women and Children's Health. While the Wall Street gang's eyes are trained on market tickers, this gathering carried significant strategic weight worth monitoring. This conference attracted over 170 key...
Continue Reading
Snagging a career after college isn't quite as easy as catching a football, but the folks over at Johns Hopkins University Athletics and Prospect HQ seem to think they have a playbook for it. You might raise an eyebrow hearing this, but Prospect HQ has now roped in student-athletes from over 500 colleges and universities nationwide into its talent pool. That's a hefty...
Continue Reading
Digging Into Ericsson's Latest Buyback Getting straight to brass tacks, the recent maneuver by Ericsson (SE0000108656)—snapping back 500,000 shares from October 26 to October 30, 2026—raised more than a few eyebrows in the financial alleys. Shelling out SEK 54.46 million in less than a week is no small potatoes, but it’s all part of a grander financial ballet...
Continue Reading
A Game Changer for Workforce Strategy You ever get the feeling businesses treat workforce planning like a jigsaw puzzle, except the pieces change shape daily? Well, TalentNeuron's out here flipping the table by introducing some fancy new capabilities that'll make those pieces fit a whole lot easier. Yeah, it's about time someone thought to merge continuous workforce...
Continue Reading
Shifting Gears with New Leadership Black Optix Tint isn't just revamping its car-styling game; it's refueling the entire brand with the appointment of Jeff Stark as its new brand president. This guy's entry into the picture is like putting nitro in the tank of a franchise that's already got some serious road miles behind it. With over 15 years under his belt in the...
Continue Reading
A New Takeoff for Airline B2B Payments Dusting off the cobwebs of traditional payment processes, YeePay has been busy at the 2026 IATA WFS & WPS, held on the glitzy floor of the Galaxy International Convention Center in Macau from October 28 to 29. They're not just chatting about travel; they're rolling out a novel way to tackle the headaches in airline B2B order...
Continue Reading
Keeping the Wireless IP Crown Against All Odds Look, I've seen dominance play out in the markets over the years, but Ceva’s stranglehold on the wireless interface IP market is something fierce. They've got a whopping 68% market share, and folks, that’s 12 times their closest competitor. Talk about leaving the competition eating dust! For a field growing at a solid...
Continue Reading
Uncovering the Stark Truth of Moderate Aortic Stenosis When you hear about heart issues, the last thing you want to think about is moderate anything. But this study out of San Diego sure throws a wrench in how we size up moderate aortic stenosis. Turns out these patients aren't just in a holding pattern—they're facing some serious storm clouds. High Stakes for...
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding the Long-Term Value of Synopsys Stock When it comes to investing, the history and performance of a stock can tell a compelling story. For Synopsys (NASDAQ: SNPS), the narrative over the last two decades is particularly impressive. This company has not only weathered various market conditions but has also delivered an annualized return of 16.31%, eclipsing...
Continue Reading
Patria's Impressive Third Quarter Performance Patria (NASDAQ: PAX) has recently announced its unaudited results for the third quarter, marking a notable achievement in its financial journey. The firm has achieved a milestone, with Assets Under Management (AUM) exceeding US$50 billion, significantly more than three times the AUM at the time of its initial public offering...
Continue Reading
Market Sentiment Shifts But Caution Lingers Tuesday’s market wrapped up with the Nasdaq making a decent little rebound, gaining roughly 1%. Ain’t that a surprise? The real kicker here is the ongoing tug-of-war between fear and greed among investors—patience is wearing thin as the CNN Money Fear and Greed Index wobbles at 42.7, still stuck in the worry zone. With...
Continue Reading
New Interactive Experience: Find Tamagotchi on Roblox transcosmos is thrilled to announce the launch of Find Tamagotchi on Roblox, a beloved interactive platform embraced worldwide. This innovative title is part of a broader initiative to engage fans of the iconic Tamagotchi franchise, which has been cherished by multiple generations. The adventure to find and learn about...
Continue Reading
Collaboration to Enhance Children's Health The partnership of Sesame Workshop and NewYork-Presbyterian aims to instill healthy habits in young children and their families. By offering free resources and engaging content, they hope to create an environment where children can thrive. Creating Joyful Learning Experiences Through this collaboration, the organizations are set...
Continue Reading